GeneDx Holdings Corp. (WGS)

GeneDx Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	60.32	105	85.21	99.68	123.93	427.08
Short-Term Investments	72.23	66.29	55.97	30.47	-	-
Cash & Short-Term Investments	132.55	171.28	141.19	130.15	123.93	427.08
Cash Growth	-1.49%	21.32%	8.48%	5.01%	-70.98%	294.96%
Accounts Receivable	83.61	74.37	37.63	32.37	42.63	0.71
Other Receivables	-	-	-	0.45	0.71	-
Total Trade Receivables	83.61	74.37	37.63	32.82	43.34	0.71
Inventory	17.82	13.95	10.65	8.78	13.67	33.46
Other Current Assets	12.38	8.69	8.5	10.6	31.68	22.96
Total Current Assets	246.36	268.29	197.97	182.34	212.62	483.54
Net Property, Plant & Equipment	87.85	69.11	58.51	59.38	84.29	62.72
Other Intangible Assets	141.35	168.48	158.6	172.63	186.65	-
Goodwill	1.64	13.52	-	-	-	-
Other Long-Term Assets	4.28	4.32	4.31	4.41	7.39	7.83
Total Assets	481.49	523.71	419.38	418.76	490.94	554.09

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	42.09	57.65	30.98	37.46	84.88	44.69
Accrued Expenses	-	-	-	-	-	20.11
Current Portion of Leases	5.71	4.4	3.34	3.65	6.12	-
Unearned Revenue	-	-	-	-	-	0.47
Other Current Liabilities	26.83	46.86	20.5	17.72	53.3	36.01
Total Current Liabilities	74.63	108.91	54.82	58.82	144.3	101.28
Long-Term Debt	96.84	48.18	51.91	52.69	6.25	11
Long-Term Leases	64.86	56.05	60.92	62.94	60.01	-
Other Long-Term Liabilities	0.94	2.4	6.48	16.3	26.68	53.71
Total Long-Term Liabilities	162.64	106.62	119.32	131.92	92.94	64.71
Total Liabilities	237.27	215.53	174.13	190.74	237.24	165.99

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0.02
Additional Paid-in Capital	1,698	1,681	1,597	1,528	1,378	963.52
Accumulated Other Comprehensive Income	0.34	0.94	0.83	0.43	-	-
Retained Earnings	-1,455	-1,373	-1,352	-1,300	-1,124	-575.44
Total Common Shareholders' Equity	244.22	308.18	245.25	228.02	253.71	388.1
Shareholders' Equity	244.22	308.18	245.25	228.02	253.71	388.1
Total Liabilities & Equity	481.49	523.71	419.38	418.76	490.94	554.09

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	167.4	108.63	116.17	119.27	72.38	11
Net Cash (Debt)	-34.85	62.66	25.02	10.88	51.55	416.08
Net Cash Growth	-	150.45%	130.04%	-78.90%	-87.61%	541.33%
Net Cash Per Share	-1.18	2.19	0.93	0.45	5.04	127.04
Book Value	244.22	308.18	245.25	228.02	253.71	388.1
Book Value Per Share	8.26	10.76	9.12	9.38	24.78	118.50
Tangible Book Value	101.23	126.18	86.65	55.39	67.06	388.1
Tangible Book Value Per Share	3.43	4.41	3.22	2.28	6.55	118.50

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 3, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error